Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1996 3
2003 1
2004 2
2005 1
2006 3
2007 3
2008 4
2009 6
2010 4
2011 5
2012 5
2013 6
2014 10
2015 9
2016 6
2017 3
2018 9
2019 7
2020 12
2021 17
2022 14
2023 20
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

142 results

Results by year

Filters applied: . Clear all
Page 1
Percutaneous vertebroplasty for osteoporotic vertebral compression fracture.
Buchbinder R, Johnston RV, Rischin KJ, Homik J, Jones CA, Golmohammadi K, Kallmes DF. Buchbinder R, et al. Cochrane Database Syst Rev. 2018 Apr 4;4(4):CD006349. doi: 10.1002/14651858.CD006349.pub3. Cochrane Database Syst Rev. 2018. PMID: 29618171 Free PMC article. Updated. Review.
Neuroprotective effects of riluzole in Alzheimer's disease: A comprehensive review.
Golmohammadi M, Mahmoudian M, Hasan EK, Alshahrani SH, Romero-Parra RM, Malviya J, Hjazi A, Najm MAA, Almulla AF, Zamanian MY, Kadkhodaei M, Mousavi N. Golmohammadi M, et al. Fundam Clin Pharmacol. 2024 Apr;38(2):225-237. doi: 10.1111/fcp.12955. Epub 2023 Sep 27. Fundam Clin Pharmacol. 2024. PMID: 37753585 Review.
BACKGROUND: Despite several hundred clinical trials of drugs that initially showed promise, there has been limited clinical improvement in Alzheimer's disease (AD). This may be attributed to the existence of at least 25 abnormal cellular pathways that underlie the disease. …
BACKGROUND: Despite several hundred clinical trials of drugs that initially showed promise, there has been limited clinical improvement in A …
miR-221 and Parkinson's disease: A biomarker with therapeutic potential.
Zamanian MY, Ivraghi MS, Gupta R, Prasad KDV, Alsaab HO, Hussien BM, Ahmed H, Ramadan MF, Golmohammadi M, Nikbakht N, Oz T, Kujawska M. Zamanian MY, et al. Eur J Neurosci. 2024 Jan;59(2):283-297. doi: 10.1111/ejn.16207. Epub 2023 Dec 3. Eur J Neurosci. 2024. PMID: 38043936 Review.
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra, leading to various motor and non-motor symptoms. ...
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra, l …
Targeting Nrf2 signaling pathway and oxidative stress by resveratrol for Parkinson's disease: an overview and update on new developments.
Zamanian MY, Parra RMR, Soltani A, Kujawska M, Mustafa YF, Raheem G, Al-Awsi L, Lafta HA, Taheri N, Heidari M, Golmohammadi M, Bazmandegan G. Zamanian MY, et al. Mol Biol Rep. 2023 Jun;50(6):5455-5464. doi: 10.1007/s11033-023-08409-1. Epub 2023 May 8. Mol Biol Rep. 2023. PMID: 37155008 Review.
Parkinson's disease (PD) as a prevalent neurodegenerative condition impairs motor function and is caused by the progressive deterioration of nigrostriatal dopaminergic (DAergic) neurons. The current therapy solutions for PD are ineffective because they could not inhibit th …
Parkinson's disease (PD) as a prevalent neurodegenerative condition impairs motor function and is caused by the progressive deteriora …
(Nano)tag-antibody conjugates in rapid tests.
Mahmoudi T, Pourhassan-Moghaddam M, Shirdel B, Baradaran B, Morales-Narváez E, Golmohammadi H. Mahmoudi T, et al. J Mater Chem B. 2021 Jul 14;9(27):5414-5438. doi: 10.1039/d1tb00571e. J Mater Chem B. 2021. PMID: 34143173 Review.
Phytochemicals toward Green (Bio)sensing.
Naghdi T, Faham S, Mahmoudi T, Pourreza N, Ghavami R, Golmohammadi H. Naghdi T, et al. ACS Sens. 2020 Dec 24;5(12):3770-3805. doi: 10.1021/acssensors.0c02101. Epub 2020 Dec 10. ACS Sens. 2020. PMID: 33301670 Review.
Therapeutic Targeting of Kruppel-Like Factor 4 and Its Pharmacological Potential in Parkinson's Disease: a Comprehensive Review.
Zamanian MY, Golmohammadi M, Amin RS, Bustani GS, Romero-Parra RM, Zabibah RS, Oz T, Jalil AT, Soltani A, Kujawska M. Zamanian MY, et al. Mol Neurobiol. 2023 Nov 24. doi: 10.1007/s12035-023-03800-2. Online ahead of print. Mol Neurobiol. 2023. PMID: 37996730 Review.
In the brain, KLF4 controls various neurophysiological and neuropathological processes, and its contribution to various neurological diseases has been widely reported. Parkinson's disease (PD) is an age-related neurodegenerative disease that might have a connection with KL …
In the brain, KLF4 controls various neurophysiological and neuropathological processes, and its contribution to various neurological disease …
Poster presentations.
Aksu F, Topacoglu H, Arman C, Atac A, Tetik S, Hasanovic A, Kulenovic A, Mornjakovic Z, Pikula B, Sarac-Hadzihalilovic A, Voljevica A, Bamac B, Colak T, Alemdar M, Dundar G, Selekler M, Dincer O, Colak E, Ozbek A, Kilic C, Kamburoglu K, Ozen T, Kavak V, Kirici Y, Oztas E, Soysal HA, Unur E, Ekinci N, Karaca O, Malakhova O, Kocaoglu M, Toker S, Taser F, Kilincoglu V, Yurtgun MF, Dalcik C, Zeybek A, Baroncini M, Peltier J, Jissendi P, Pruvo JP, Francke JP, Prevot V, Kosif R, Arifoglu Y, Diramali M, Sarsilmaz M, Kose E, Ogeturk M, Akpinar B, Kus I, Meydan S, Kara A, Kurtoglu Z, Tekdemir I, Elhan A, Bas O, Odaci E, Mollaoglu H, Ucok K, Kaplan S, Senoglu M, Nacitarhan V, Kurutas EB, Senoglu N, Altun I, Atli Y, Ozbag D, Karakas S, Bilgin MD, Tellioglu AM, Ozlem S, Akcanal B, Yildiz Y, Gunes H, Kose H, Uzum I, Gundogmus UN, Caglayan C, Pavlova V, Dimitrova M, Georgieva L, Nikolova E, Uzmansel D, Ozturk NC, Saylam CY, Ozgiray E, Orhan M, Cagli S, Zileli M, Ozkan D, Akkaya T, Comert A, Balikci N, Ozdemir E, Gumus H, Ergul Z, Kaya O, Altun S, Unlu RE, Orbay H, Kim DI, Han SH, Kim YS, Kim HJ, Lee KS, Elcioglu O, Ozden H, Guven G, Imre N, Yalcin B, Ozan H, Akyer P, Guvencer M, Karatosun V, Sa… See abstract for full author list ➔ Aksu F, et al. Surg Radiol Anat. 2009 Sep;31 Suppl 1:95-229. doi: 10.1007/BF03371486. Surg Radiol Anat. 2009. PMID: 27392492 No abstract available.
142 results